Why is Alembic Pharma falling/rising?

As of 03-Jul, Alembic Pharmaceuticals Ltd. is experiencing a price increase, currently at 1,008.40, reflecting a rise of 18.75 or 1.89%. The stock has shown a positive trend today, outperforming its sector by 1.41% and reversing a two-day decline. It reached an intraday high of Rs 1012.05, and is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Despite this positive movement, the stock has seen a significant drop in delivery volume, falling by 64.7% against the 5-day average, indicating a decrease in investor participation. Over the past year, while the stock has generated a return of 6.15%, its profits have declined by 7%, although it maintains a strong ability to service debt with a low Debt to EBITDA ratio of 0.67 times and an attractive valuation compared to peers.
In the broader market context, Alembic Pharmaceuticals has outperformed the Sensex in the short term, with a 1-week return of +3.53% compared to the benchmark's -0.62%. However, year-to-date, the stock is down 4.79%, while the Sensex has gained 6.53%. The high institutional holdings at 20.37% suggest that these investors, who typically have better resources to analyze company fundamentals, may be supporting the stock's recent upward movement despite the mixed performance indicators. Overall, while the stock is currently rising, the decline in delivery volume and the drop in profits present challenges that investors should consider.